Outset Medical, Inc.
OM
$14.20
$0.533.88%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 5.60% | 0.97% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 5.60% | 0.97% | |||
| Cost of Revenue | 4.63% | 3.00% | |||
| Gross Profit | 7.24% | -2.30% | |||
| SG&A Expenses | 6.60% | 0.65% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.60% | 0.85% | |||
| Operating Income | -2.79% | -0.63% | |||
| Income Before Tax | 28.17% | -0.10% | |||
| Income Tax Expenses | -9.57% | 2,975.00% | |||
| Earnings from Continuing Operations | 28.09% | -0.57% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 28.09% | -0.57% | |||
| EBIT | -2.79% | -0.63% | |||
| EBITDA | -3.95% | -1.44% | |||
| EPS Basic | 71.47% | 49.76% | |||
| Normalized Basic EPS | 59.35% | 55.25% | |||
| EPS Diluted | 71.47% | 49.76% | |||
| Normalized Diluted EPS | 59.35% | 55.25% | |||
| Average Basic Shares Outstanding | 152.10% | 100.16% | |||
| Average Diluted Shares Outstanding | 152.10% | 100.16% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||